Transplant-associated thrombotic microangiopathy: theoretical considerations and a practical approach to an unrefined diagnosis
JA Young, CR Pallas, MA Knovich - Bone Marrow Transplantation, 2021 - nature.com
Transplant-associated thrombotic microangiopathy (TA-TMA) is an increasingly recognized
complication of hematopoietic stem cell transplant (HSCT) with high morbidity and mortality …
complication of hematopoietic stem cell transplant (HSCT) with high morbidity and mortality …
Transplant-associated thrombotic microangiopathy in pediatric hematopoietic cell transplant recipients: a practical approach to diagnosis and management
CC Dvorak, C Higham, KA Shimano - Frontiers in Pediatrics, 2019 - frontiersin.org
Transplant-associated thrombotic microangiopathy (TA-TMA) is an endothelial damage
syndrome that is increasingly identified as a complication of both autologous and allogeneic …
syndrome that is increasingly identified as a complication of both autologous and allogeneic …
[HTML][HTML] Harmonizing definitions for diagnostic criteria and prognostic assessment of transplantation-associated thrombotic microangiopathy: a report on behalf of the …
ML Schoettler, E Carreras, B Cho, CE Dandoy… - … and cellular therapy, 2023 - Elsevier
Transplantation-associated thrombotic microangiopathy (TA-TMA) is an increasingly
recognized complication of hematopoietic cell transplantation (HCT) associated with …
recognized complication of hematopoietic cell transplantation (HCT) associated with …
Narsoplimab, a mannan-binding lectin-associated serine protease-2 inhibitor, for the treatment of adult hematopoietic stem-cell transplantation–associated thrombotic …
SK Khaled, K Claes, YT Goh, YL Kwong… - Journal of Clinical …, 2022 - ascopubs.org
PURPOSE Hematopoietic stem-cell transplantation–associated thrombotic microangiopathy
(HSCT-TMA) is a serious complication with significant mortality and no approved therapy …
(HSCT-TMA) is a serious complication with significant mortality and no approved therapy …
Incidence, risk factors for and outcomes of transplant‐associated thrombotic microangiopathy
Transplant‐associated thrombotic microangiopathy (TA‐TMA) is a complication of
allogeneic transplantation (allo‐HCT). The incidence and risk factors associated with TA …
allogeneic transplantation (allo‐HCT). The incidence and risk factors associated with TA …
Endothelial dysfunction syndromes after allogeneic stem cell transplantation
D Vythoulkas, P Tsirigotis, M Griniezaki, I Konstantellos… - Cancers, 2023 - mdpi.com
Simple Summary Hemato-poietic stem cell transplantation is associated with significant
endothelial dysfunction, which may result in severe complications. Endothelial dysfunction …
endothelial dysfunction, which may result in severe complications. Endothelial dysfunction …
The role of complement in HSCT-TMA: basic science to clinical practice
S Meri, D Bunjes, R Cofiell, S Jodele - Advances in Therapy, 2022 - Springer
Hematopoietic stem cell transplantation-associated thrombotic microangiopathy (HSCT-
TMA) is a common complication occurring post-HSCT and is associated with substantial …
TMA) is a common complication occurring post-HSCT and is associated with substantial …
Role of the lectin pathway of complement in hematopoietic stem cell transplantation-associated endothelial injury and thrombotic microangiopathy
E Gavriilaki, VT Ho, W Schwaeble, T Dudler… - … hematology & oncology, 2021 - Springer
Hematopoietic stem cell transplantation-associated thrombotic microangiopathy (HSCT-
TMA) is a life-threatening syndrome that occurs in adult and pediatric patients after …
TMA) is a life-threatening syndrome that occurs in adult and pediatric patients after …
[HTML][HTML] Transplant-associated thrombotic microangiopathy is a multifactorial disease unresponsive to immunosuppressant withdrawal
Transplant-associated thrombotic microangiopathy (TA-TMA) after allogeneic hematopoietic
cell transplantation (HCT) has not been well characterized in large population studies with …
cell transplantation (HCT) has not been well characterized in large population studies with …
Risk factors for transplant-associated thrombotic microangiopathy and mortality in a pediatric cohort
M Schoettler, LE Lehmann, S Margossian… - Blood …, 2020 - ashpublications.org
Transplant-associated thrombotic microangiopathy (TA-TMA) is a well-recognized
complication of hematopoietic cell transplantation (HCT). Diagnosis is challenging and in …
complication of hematopoietic cell transplantation (HCT). Diagnosis is challenging and in …